FR22C1003I1 - - Google Patents
Info
- Publication number
- FR22C1003I1 FR22C1003I1 FR22C1003C FR22C1003I1 FR 22C1003 I1 FR22C1003 I1 FR 22C1003I1 FR 22C1003 C FR22C1003 C FR 22C1003C FR 22C1003 I1 FR22C1003 I1 FR 22C1003I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34837610P | 2010-05-26 | 2010-05-26 | |
| PCT/SE2011/050652 WO2011149419A1 (en) | 2010-05-26 | 2011-05-25 | Vaccine against streptococcal infections based on recombinant proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR22C1003I1 true FR22C1003I1 (en) | 2022-02-18 |
| FR22C1003I2 FR22C1003I2 (en) | 2023-02-03 |
Family
ID=45004197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR22C1003C Active FR22C1003I2 (en) | 2010-05-26 | 2022-01-12 | VACCINE AGAINST STREPTOCOCCAL INFECTIONS BASED ON RECOMBINATION PROTEINS |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9333252B2 (en) |
| EP (2) | EP2590994B1 (en) |
| CN (1) | CN103068838B (en) |
| AU (1) | AU2011258898B2 (en) |
| CA (1) | CA2799136A1 (en) |
| ES (2) | ES2948841T3 (en) |
| FR (1) | FR22C1003I2 (en) |
| HK (1) | HK1183677A1 (en) |
| NL (1) | NL301156I2 (en) |
| WO (1) | WO2011149419A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2498812A4 (en) * | 2009-11-13 | 2013-05-22 | Bengt Guss | Immunizing composition for reducing streptococcal infections |
| EP2949340A1 (en) * | 2014-05-30 | 2015-12-02 | IDT Biologika GmbH | Vaccine composition against Streptococcus suis infection |
| GB201502306D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| GB201502305D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| CN104789587B (en) * | 2015-04-10 | 2018-04-27 | 新疆农业大学 | Eukaryotic expression recombinant plasmid compound is preparing the application of strangles hammer bacteria vaccine |
| JP2023532219A (en) * | 2020-06-18 | 2023-07-27 | 上海宝済薬業有限公司 | Immunoglobulin degrading enzyme IdeE mutant |
| CN112011479B (en) * | 2020-08-06 | 2022-04-22 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | Streptococcus equi subsp equi HLJ2018D-LX strain and application thereof in preparation of streptococcus equi subsp equi inactivated vaccine |
| CN114437235B (en) * | 2022-01-04 | 2024-02-09 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | Recombinant fusion protein of streptococcus equi subspecies 8 proteins, and preparation method and application thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR241545A1 (en) | 1985-07-12 | 1992-08-31 | Cornell Res Foundation Inc | The protection of equines against streptococcus equi |
| US5583014A (en) | 1990-07-03 | 1996-12-10 | Bayer Corporation | Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine |
| SE9302855D0 (en) | 1993-09-06 | 1993-09-06 | Martin Lindberg | Method and means for producing plasma proteinase inhibitor binding proteins |
| IES76925B2 (en) | 1996-07-03 | 1997-11-19 | Provost | Subunit Vaccine for Streptococcus Equi |
| FR2750999B1 (en) | 1996-07-10 | 1998-11-20 | Appligene Oncor | THERMOSTABLE DNA POLYMERASE OF ARCHAEBACTERIA OF THE GENUS PYROCOCCUS SP |
| SE9804491D0 (en) | 1998-12-22 | 1998-12-22 | Bengt Guss | Novel fibronectin binding protein |
| WO2004032957A1 (en) | 2002-10-11 | 2004-04-22 | Bengt Guss | Immunization of non-human mammals against streptococcus equi |
| EP2019687B1 (en) | 2006-03-29 | 2014-03-19 | Merial Limited | Vaccine against streptococci |
| GB0624874D0 (en) * | 2006-12-13 | 2007-01-24 | Hansa Medical Ab | Treatment |
| CN101889082A (en) | 2007-09-14 | 2010-11-17 | 季诺维斯公司 | Method and kits for dissociating Fcgamma-receptor-IgG complexes and for igg purification and detection |
| WO2009075646A1 (en) * | 2007-12-13 | 2009-06-18 | Bengt Guss | Improved immunizing composition |
| GB0801326D0 (en) | 2008-01-24 | 2008-03-05 | Animal Health Trust | Vaccines |
| CN103897045A (en) * | 2009-01-12 | 2014-07-02 | 诺华股份有限公司 | Cna_b domain antigens in vaccines against gram positive bacteria |
| EP2498812A4 (en) | 2009-11-13 | 2013-05-22 | Bengt Guss | Immunizing composition for reducing streptococcal infections |
-
2011
- 2011-05-25 CA CA2799136A patent/CA2799136A1/en not_active Abandoned
- 2011-05-25 EP EP11786995.8A patent/EP2590994B1/en active Active
- 2011-05-25 ES ES16193491T patent/ES2948841T3/en active Active
- 2011-05-25 ES ES11786995.8T patent/ES2612520T3/en active Active
- 2011-05-25 AU AU2011258898A patent/AU2011258898B2/en active Active
- 2011-05-25 US US13/683,522 patent/US9333252B2/en active Active
- 2011-05-25 WO PCT/SE2011/050652 patent/WO2011149419A1/en active Application Filing
- 2011-05-25 CN CN201180026088.9A patent/CN103068838B/en active Active
- 2011-05-25 EP EP16193491.4A patent/EP3135684B1/en active Active
-
2013
- 2013-09-27 HK HK13111087.6A patent/HK1183677A1/en unknown
-
2015
- 2015-12-04 US US14/959,672 patent/US9795664B2/en active Active
-
2021
- 2021-12-23 NL NL301156C patent/NL301156I2/en unknown
-
2022
- 2022-01-12 FR FR22C1003C patent/FR22C1003I2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2799136A1 (en) | 2011-12-01 |
| CN103068838A (en) | 2013-04-24 |
| ES2612520T3 (en) | 2017-05-17 |
| EP3135684B1 (en) | 2023-06-28 |
| AU2011258898A1 (en) | 2012-11-29 |
| FR22C1003I2 (en) | 2023-02-03 |
| WO2011149419A1 (en) | 2011-12-01 |
| EP3135684C0 (en) | 2023-06-28 |
| US20160082096A1 (en) | 2016-03-24 |
| US9333252B2 (en) | 2016-05-10 |
| ES2948841T3 (en) | 2023-09-20 |
| EP2590994A4 (en) | 2014-04-30 |
| EP2590994B1 (en) | 2016-11-02 |
| US9795664B2 (en) | 2017-10-24 |
| US20130236469A1 (en) | 2013-09-12 |
| AU2011258898B2 (en) | 2015-05-07 |
| CN103068838B (en) | 2016-03-02 |
| NL301156I2 (en) | 2022-03-11 |
| EP3135684A1 (en) | 2017-03-01 |
| HK1183677A1 (en) | 2014-01-03 |
| EP2590994A1 (en) | 2013-05-15 |